VEGFA and obesity due to melanocortin 4 receptor deficiency: These data suggest that, in mice, promoting angiogenesis in the early stages of obesity may be beneficial, thereby opening new avenues for the potential use of manipulating angiogenesis via VEGFA administration in obese patients.